Related Experiment Videos
Mechanical and other factors relating to left ventricular hypertrophy
R Fagard1, P Lijnen, J Staessen
1Department of Pathophysiology, University of Leuven, K.U.L., Belgium.
Blood Pressure. Supplement
|January 1, 1994
Summary
Left ventricular hypertrophy in hypertension is not strongly linked to blood pressure alone. Antihypertensive treatments show similar efficacy in reducing left ventricular mass, regardless of drug class.
Area of Science:
- Cardiology
- Hypertension Research
- Pharmacology
Background:
- Left ventricular hypertrophy (LVH) in hypertension is typically attributed to increased pressure load and wall tension.
- The correlation between left ventricular mass and conventional blood pressure measurements is often weak, even with advanced monitoring.
- Factors beyond blood pressure, such as genetics and lifestyle, may influence LVH development.
Purpose of the Study:
- To investigate the relationship between blood pressure and left ventricular mass.
- To evaluate the effectiveness of different antihypertensive drug classes in reducing left ventricular mass.
- To identify factors influencing left ventricular hypertrophy in hypertensive patients.
Main Methods:
- Review of studies examining the correlation between blood pressure measurements (conventional and 24-h monitoring) and left ventricular mass.
- Meta-analysis of prospective, randomized, comparative studies on antihypertensive treatments.
- Comparison of drug classes including diuretics, beta-blockers, calcium antagonists, and angiotensin-converting enzyme (ACE) inhibitors.
Main Results:
- Conventional blood pressure measurements and even 24-h monitoring explain a limited portion of left ventricular mass variation.
- Antihypertensive treatments, including diuretics, beta-blockers, calcium antagonists, and ACE inhibitors, demonstrate similar efficacy in reducing left ventricular mass.
- Specific comparisons indicated no significant difference in LVH reduction between ACE inhibitors and calcium antagonists.
- Agents like minoxidil and hydralazine were found not to reduce left ventricular mass.
Conclusions:
- Blood pressure alone is an insufficient predictor of left ventricular hypertrophy.
- Current major classes of antihypertensive drugs are similarly effective in reducing left ventricular mass.
- Further research may be needed to explore other contributing factors to LVH beyond blood pressure and standard treatments.